Ninghua Tan Selected Research

Cough-Variant Asthma

1/2022	Suhuang antitussive capsule ameliorates post-infectious cough in mice through AhR-Nrf2 pathway.
5/2021	Preservation of mitochondrial homeostasis is responsible for the ameliorative effects of Suhuang antitussive capsule on non-resolving inflammation via inhibition of NF-κB signaling and NLRP3 inflammasome activation.
2/2020	Identification of quality control markers in Suhuang antitussive capsule based on HPLC-PDA fingerprint and anti-inflammatory screening.
10/2019	Suhuang antitussive capsule inhibits NLRP3 inflammasome activation and ameliorates pulmonary dysfunction via suppression of endoplasmic reticulum stress in cough variant asthma.
1/2019	Suhuang Antitussive Capsules-Ameliorative Effects on LPS-Induced Sputum Obstruction in Mice Through Promoting HGF Secretion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ninghua Tan Research Topics

Disease

21	Neoplasms (Cancer) 06/2022 - 10/2005
5	Inflammation (Inflammations) 01/2022 - 08/2011
5	Cough-Variant Asthma 01/2022 - 01/2019
4	Cough 01/2022 - 01/2019
2	Colonic Neoplasms (Colon Cancer) 06/2022 - 01/2021
2	Colitis 06/2022 - 08/2011
2	Hypoxia (Hypoxemia) 12/2019 - 07/2018
2	Liver Neoplasms (Liver Cancer) 05/2019 - 11/2017
2	Fatigue 03/2016 - 12/2014
1	Colitis-Associated Neoplasms 06/2022
1	Airway Remodeling 01/2022
1	Hyperglycemia 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Wounds and Injuries (Trauma) 09/2021
1	Stress Urinary Incontinence 10/2020
1	Insulin Resistance 06/2020
1	Fibrosis (Cirrhosis) 04/2020
1	Bites and Stings (Sting) 12/2018
1	Autoimmune Diseases (Autoimmune Disease) 12/2018
1	Infections 12/2018
1	Carcinogenesis 11/2018
1	Phototoxic Dermatitis (Phototoxicity) 07/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2018
1	Septic Shock (Toxic Shock Syndrome) 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 11/2017

Drug/Important Bio-Agent (IBA)

14	Cyclic PeptidesIBA 06/2022 - 09/2009
6	RA VIBA 12/2019 - 01/2017
5	RA XIIIBA 06/2022 - 11/2017
5	Capsules (Microcapsules)IBA 01/2022 - 01/2019
5	Antitussive Agents (Antitussives)FDA Link 01/2022 - 01/2019
3	Liposomes (Liposome)IBA 01/2021 - 07/2018
2	Phosphotransferases (Kinase)IBA 11/2021 - 06/2018
2	Nonprescription Drugs (Patent Medicines)IBA 05/2021 - 02/2020
2	InflammasomesIBA 05/2021 - 10/2019
2	Pharmaceutical PreparationsIBA 01/2021 - 11/2018
2	AntibodiesIBA 12/2019 - 07/2018
2	astin CIBA 12/2018 - 08/2011
2	Peptides (Polypeptides)IBA 01/2017 - 01/2013
2	Serotonin (5 Hydroxytryptamine)IBA 03/2016 - 12/2014
2	CyclotidesIBA 08/2011 - 08/2010
2	Cysteine Proteases (Cysteine Protease)IBA 04/2006 - 10/2005
1	AzoxymethaneIBA 06/2022
1	Dextran SulfateIBA 06/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	EnzymesIBA 01/2022
1	ImmunosorbentsIBA 01/2022
1	Retinaldehyde (Retinal)IBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Sirtuin 1IBA 01/2022
1	pyrimidineIBA 11/2021
1	N-methylpicolinamideIBA 11/2021
1	thienopyrimidineIBA 11/2021
1	Biological ProductsIBA 11/2021
1	SolventsIBA 11/2021
1	GelatinIBA 09/2021
1	Photosensitizing Agents (Photosensitizers)IBA 01/2021
1	Hyaluronic Acid (Hyaluronan)IBA 01/2021
1	PorphyrinsIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 06/2020
1	AndrogensIBA 06/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2020
1	NF-kappa B (NF-kB)IBA 04/2020
1	4-octyl itaconateIBA 04/2020
1	Adenine FDA LinkGeneric 04/2020
1	Death Domain ReceptorsIBA 12/2019
1	Antisense OligonucleotidesIBA 12/2019
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 12/2019
1	Triglycerides (Triacylglycerol)IBA 05/2019
1	SREBP cleavage-activating proteinIBA 05/2019
1	GlycosidesIBA 05/2019
1	Small Interfering RNA (siRNA)IBA 05/2019
1	CatalaseIBA 01/2019
1	DisulfidesIBA 01/2019
1	Mucin 5ACIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 11/2018
1	NitroreductasesIBA 07/2018
1	4,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA 07/2018
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 07/2018
1	Cytochromes c (Cytochrome c)IBA 01/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017
1	acteosideIBA 03/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2015
1	Antimalarials (Antimalarial Agents)IBA 01/2013
1	RA VIIIBA 09/2009
1	isodityrosineIBA 09/2009
1	yakuchinone BIBA 04/2009
1	isovanillinIBA 04/2009
1	tectochrysinIBA 04/2009
1	yakuchinone-AIBA 04/2009
1	Cathepsin KIBA 04/2006

Therapy/Procedure

5	Therapeutics 01/2021 - 01/2017
3	Drug Therapy (Chemotherapy) 11/2021 - 01/2019
2	Oral Administration 11/2021 - 08/2011
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2019 - 11/2017
2	Precision Medicine 01/2019 - 07/2018
1	Transplantation 01/2021
1	Lasers (Laser) 01/2021
1	Electroacupuncture 10/2020
1	Photochemotherapy (Photodynamic Therapy) 07/2018